Balchem Corporation (BCPC)
Nasdaq · Basic Materials · Specialty Chemicals
$166.04−0.31%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $5.3B
- P/E (trailing)
- 32.7
- Forward P/E
- 26.5
- Dividend yield
- 0.6%
- 52-week range
- $139.17 – $183.90
- 52-week change
- +17.98%
- EPS (trailing)
- $5.08
- Next earnings
- Oct 20, 2026
Fiscal year to Dec 2025
- Revenue
- $1.0B (+8.76%)
- Net income
- $155M
- Operating margin
- 20.2%
- Diluted EPS
- $4.75
From the company’s annual report on SEC EDGAR.
About Balchem Corporation
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications.
Headquarters: Montvale, United States · 1,379 employees · balchem.com